KARBE FRANK received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2025ACC: 0000950170-25-082458
+28K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
28K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.50K
Price / share
—
Trade value
—
% of position
18.4%
6/3/2025
57K→67.50K
Total
Net shares
+10.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | A · Award | +10.50K | — | — | 18.4% | 57K | 67.50K |
| Total | +10.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.50K shares
Shares
+17.50K
Strike price
4.95
Held after
17.50K
Exercisable
—
6/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.50K shares | 6/3/2025 | A · Award | +17.50K | 4.95 | — | 17.50K |